Population under study
standards;All, HCC, Cancer
MAY, RECURRENCE, CANCER
A total of 227 HCC patients with definitive recurrence information who had undergone a macroscopic R0 resection at the Guangxi Medical University Cancer Hospital in Nanning, Guangxi Province, China, between June 2014 and May 2019 were enrolled. The inclusion criteria were: (1) a conclusive pathological diagnosis of HCC according to the world Health Organization's standards;All patients (Flow chart of patient enrollment.The Guangxi Medical University Cancer Hospital's ethical committee approved the study protocol (No. LW2022154). Each patient provided their informed permission in writing.